This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Noxxon Pharma Ag, Aptarion Biotech Ag. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2025
Title: Innovations of Inventor Kai Hohlig
Introduction
Kai Hohlig is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules. With a total of 7 patents, Hohlig's work has the potential to impact various medical applications.
Latest Patents
Hohlig's latest patents include groundbreaking inventions such as CXCL8 binding nucleic acids. This invention relates to an L-nucleic acid molecule capable of binding to human CXCL8, featuring a specific nucleotide sequence. Another notable patent is for C5a binding nucleic acids, which involves a nucleic acid molecule designed to bind to human C5a, incorporating a unique nucleotide sequence.
Career Highlights
Throughout his career, Hohlig has worked with notable companies in the biotechnology sector, including Noxxon Pharma AG and Aptarion Biotech AG. His expertise in nucleic acid technology has positioned him as a valuable asset in these organizations.
Collaborations
Hohlig has collaborated with several professionals in his field, including Christian Maasch and Sven Klussmann. These partnerships have fostered innovation and advancement in his research endeavors.
Conclusion
Kai Hohlig's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile